Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic

By Keck Jr Paul E   McElroy Susan L  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 4, 2003-04 ,pp. : 655-662

Informa Healthcare

Access to resources Recommend Favorite

Enhancement of antipsychotic-like properties of the dopamine D 2 receptor antagonist, raclopride, by the additional treatment with the 5-HT 2 receptor blocking agent, ritanserin, in the rat

By Wadenberg M.-L.   Salmi P.   Jimenez P.   Svensson T.   Ahlenius S.  

European Neuropsychopharmacology, Vol. 6, Iss. 4, 1996-11 ,pp. : 305-310

Elsevier

Access to resources Recommend Favorite

Effects of acute and repeated treatment with a novel dopamine D 2 receptor ligand on l-DOPA-induced dyskinesias in MPTP monkeys

By Tahar A.H.   Ekesbo A.   Gregoire L.   Bangassoro E.   Svensson K.A.   Tedroff J.   Bedard P.J.  

European Journal of Pharmacology, Vol. 412, Iss. 3, 2001-02 ,pp. : 247-254

Elsevier

Access to resources Recommend Favorite

In vivo occupancy of dopamine D₂ receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles

By Assié Marie-Bernadette   Dominguez Hélène   Consul-Denjean Nathalie   Newman-Tancredi Adrian  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 373, Iss. 6, 2006-09 ,pp. : 441-450

Springer Publishing Company

Access to resources Recommend Favorite

Differential effects of repeated administration of novel antipsychotic drugs on the activity of midbrain dopamine neurons in the rat

By Skarsfeldt T.  

European Journal of Pharmacology, Vol. 281, Iss. 3, 1995-08 ,pp. : 289-294

Elsevier

Access to resources Recommend Favorite